Company Valuation: Boston Scientific Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 60,534 66,273 84,691 131,642 141,351 80,412 - -
Change - 9.48% 27.79% 55.44% 7.37% -43.11% - -
Enterprise Value (EV) 1 67,674 74,280 92,928 141,974 150,822 86,706 83,311 79,310
Change - 9.76% 25.1% 52.78% 6.23% -42.51% -3.92% -4.8%
P/E ratio 61.6x 103x 54x 71.5x 49.1x 19.9x 18.9x 16.5x
PBR 3.64x 3.77x 4.39x 6.05x 5.84x 2.88x 2.54x 2.28x
PEG - -3x 0x 4.3x 0.9x 0.5x 3.35x 1.2x
Capitalization / Revenue 5.09x 5.23x 5.95x 7.86x 7.04x 3.71x 3.4x 3.13x
EV / Revenue 5.69x 5.86x 6.53x 8.48x 7.51x 4x 3.53x 3.09x
EV / EBITDA 16.5x 20.8x 22.6x 29.3x 25.3x 13x 11.3x 9.68x
EV / EBIT 22.5x 22.9x 24.9x 31.3x 26.9x 14.1x 12.3x 10.5x
EV / FCF 51.4x 79.2x 51.9x 53.7x 41.2x 20.7x 19.8x 14.9x
FCF Yield 1.94% 1.26% 1.93% 1.86% 2.43% 4.84% 5.06% 6.72%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 0.69 0.45 1.07 1.25 1.94 2.713 2.866 3.272
Distribution rate - - - - - - - -
Net sales 1 11,888 12,682 14,240 16,747 20,074 21,680 23,618 25,659
EBITDA 1 4,103 3,574 4,106 4,839 5,973 6,681 7,391 8,196
EBIT 1 3,010 3,241 3,738 4,529 5,612 6,170 6,799 7,533
Net income 1 985 642 1,570 1,853 2,898 3,958 4,177 4,890
Net Debt 1 7,140 8,007 8,237 10,332 9,471 6,294 2,899 -1,102
Reference price 2 42.48 46.27 57.81 89.32 95.35 54.10 54.10 54.10
Nbr of stocks (in thousands) 1,424,992 1,432,311 1,464,983 1,473,827 1,482,442 1,486,355 - -
Announcement Date 02/02/22 01/02/23 31/01/24 05/02/25 04/02/26 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
19.94x4x12.98x-.--% 80.41B
22.74x4.22x16.25x0.4% 171B
47.43x12.42x27.85x-.--% 153B
26.36x4.97x15.5x0.89% 118B
28.29x6.28x19.98x-.--% 45.91B
17.67x2.07x10.54x2.95% 44.35B
36.28x6.03x18.39x-.--% 34.57B
21.65x4.44x15.39x0.9% 31.91B
23.27x5.04x15.7x2.7% 29.63B
19.23x5.07x12.94x1.19% 29.56B
Average 26.29x 5.45x 16.55x 0.9% 73.76B
Weighted average by Cap. 28.64x 6.18x 17.97x 0.61%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. BSX Stock
  4. Valuation Boston Scientific Corporation